Conference Coverage

TCT: Novel drug-coated stent bests bare-metal in patients at high bleeding risk

Publish date: October 14, 2015

 

AT TCT 2015

References

LEADERS FREE was underwritten by Biosensors International, maker of the BioFreedom stent. Dr. Urban and several of his coinvestigators disclosed relationships with device makers, including Edward Lifesciences, Terumo, Abbott Vascular, and Quest Medical.

wmcknight@frontlinemedcom.com

On Twitter @whitneymcknight

Pages

Recommended Reading

Right-side mini-AVR an option for frail patients
MDedge Internal Medicine
ESC: Bivalirudin no better than unfractionated heparin in PCI
MDedge Internal Medicine
ESC: Ticagrelor linked to less bypass-related bleeding
MDedge Internal Medicine
Women dogged by unplanned readmissions after aortic surgery
MDedge Internal Medicine
ESC: What’s the hottest recent advance in cardiology? And the winner is …
MDedge Internal Medicine
TCT: Absorb BVS meets pivotal U.S. noninferiority goal
MDedge Internal Medicine
TCT: Routine thrombectomy with PCI raises stroke risk 66% in STEMI patients
MDedge Internal Medicine
TCT: FFR-CT improved costs, quality of life in PLATFORM trial
MDedge Internal Medicine
TCT: Ranolazine fails to block angina after incomplete revascularization
MDedge Internal Medicine
TCT: No difference at 2 years between Absorb BVS and XIENCE
MDedge Internal Medicine

Related Articles